Vertex Pharmaceuticals Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $10.10B | $6.80B |
| FY2022 | — | $13.91B | $10.50B |
| FY2023 | — | $17.58B | $10.37B |
| FY2024 | — | $16.41B | $4.57B |
| FY2025 | — | $18.67B | $5.08B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $10.10B | $6.80B |
| FY2022 | — | $13.91B | $10.50B |
| FY2023 | — | $17.58B | $10.37B |
| FY2024 | — | $16.41B | $4.57B |
| FY2025 | — | $18.67B | $5.08B |